ArticleTherapeutic advances in respiratory disease

The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reports.

Qing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.